ArticleEuropean journal of medical research2025
Association between De Ritis ratio and mortality in individuals with diabetes or prediabetes: evidence from NHANES (1999-2018).
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe De Ritis ratio (AST/ALT) has emerged as a potential biomarker for metabolic dysfunction, but its association with mortality in individuals with diabetes or prediabetes remains inadequately explored. This study investigated the relationship between the De Ritis ratio and mortality in this population.
methodsWe analyzed data from 23,873 participants with diabetes or prediabetes from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. Participants were stratified into quartiles based on De Ritis ratio values. Cox proportional hazards regression models were employed to assess mortality risk, adjusting for demographic, lifestyle, and clinical factors. Restricted cubic spline (RCS) analysis examined potential non-linear relationships.
resultsDuring follow-up through December 2019, higher De Ritis ratios were associated with increased mortality risk. In fully adjusted models, the highest quartile showed significantly elevated risks for all-cause mortality (HR: 1.79, 95% CI 1.56-2.05) and CVD mortality (HR: 1.66, 95% CI 1.30-2.12) versus the lowest quartile. Each SD increase in De Ritis ratio corresponded to 26% and 28% increased risks for all-cause and CVD mortality, respectively. The association remained linear across examined values, with the De Ritis ratio showing superior predictive performance compared to individual liver enzymes.
conclusionsElevated De Ritis ratio is independently associated with increased all-cause and CVD mortality in individuals with diabetes or prediabetes, suggesting its potential utility as a prognostic biomarker for clinical risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.